Immunodiagnostics Market Intelligence Report Covers Trends, Segments And Regional Growth

The immunodiagnostics sector is set for remarkable expansion in the coming years, driven by technological advancements and shifting healthcare priorities. This market is increasingly critical for early disease detection and personalized treatment, reflecting broader trends in medical diagnostics.

Projected Market Size and Growth Prospects of the Immunodiagnostics Market
The immunodiagnostics market is anticipated to reach a value of $35.76 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.1%. This robust expansion is fueled by greater adoption of personalized diagnostic tools, increased investments in automated laboratory equipment, the broadening utilization of point-of-care immunodiagnostic devices, and the rising integration of artificial intelligence for interpreting test results. Additionally, a heightened focus on preventive healthcare testing contributes significantly to market growth. Key trends shaping the industry include the wider use of automated immunoassay analyzers, growing demand for highly sensitive diagnostic tests, rapid immunodiagnostic kit adoption, development of multiplex testing capabilities, and the improved integration of laboratory data management systems.

Download a free sample of the immunodiagnostics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Drivers Behind the Growth of the Immunodiagnostics Market
The rising preference for personalized diagnostics is playing a pivotal role in expanding the immunodiagnostics sector. Tailored diagnostic solutions help clinicians provide more precise patient care, encouraging healthcare providers to invest in advanced immunodiagnostic technologies.
Simultaneously, there is an increasing push towards automation in labs, which improves efficiency and accuracy. Automated systems reduce manual errors and speed up test processing, making laboratories more productive and capable of handling larger volumes of tests.

Leading Players Influencing the Immunodiagnostics Industry
Several prominent companies dominate the immunodiagnostics landscape, including Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., bioMérieux SA, Sysmex Corporation, Becton dic*kinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp., OraSure Technologies Inc., and Immunodiagnostic Systems Holdings Plc (IDS).

View the full immunodiagnostics market report:
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Strategic Moves Enhancing Market Position
In May 2023, Freenome, a biotechnology firm from the United States, completed its acquisition of Oncimmune, a UK-based biotech company known for immune profiling and biomarker discovery in cancer diagnosis. This acquisition aims to boost Freenome's early cancer detection capabilities by integrating Oncimmune's cutting-edge technologies, thereby strengthening its foothold in the oncology diagnostics arena and expanding its liquid biopsy offerings.

Innovative Trends Transforming the Immunodiagnostics Field
Industry leaders are actively developing advanced solutions such as automated chemiluminescence immunoassays (CLIAs) to improve test precision, shorten turnaround times, and enhance laboratory workflow. CLIAs utilize light-emitting chemical reactions combined with automation to detect specific proteins or antibodies in patient samples rapidly.
For example, in September 2025, DiaSorin S.p.A. launched the LIAISON® TSH-R Ab assay designed for assessing autoimmune thyroid disorders. This new test features improved antibody specificity through a double-bridge assay design and can integrate seamlessly with existing LIAISON analyzers, streamlining lab processes. Moreover, it is CE-marked, allowing deployment across multiple regulated markets.

Dominant Segments Within the Immunodiagnostics Market
The immunodiagnostics market is divided into several key segments:
1) Product Types: Reagents and Consumables, Instruments
2) Technologies: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Fluorescent Immunoassay, Rapid Tests, and other technologies
3) Applications: Infectious Diseases, Oncology and Endocrinology, Bone and Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, and other applications
4) End Users: Hospitals, Clinics, Diagnostic Laboratories

Further subcategories include:
- Reagents and Consumables such as antibodies, assay kits, buffers, and substrates
- Instruments including immunoassay analyzers and ELISA readers

This segmentation highlights the diverse and specialized nature of the immunodiagnostics market, catering to a wide range of healthcare needs and settings.

Expanded capabilities in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.